Drug Abuse and Addiction: Pharmacological Phenomena

Tolerance is a reduced drug response after repeated use, while addiction is compulsive, out-of-control drug use driven by brain reward circuits. Tolerance involves pharmacological adaptation and can occur without addiction. Addiction is characterized by loss of control and continued use despite harmful consequences. Understanding this distinction is critical for physicians prescribing medications.

Addictive drugs elevate dopamine levels in the mesolimbic system, which originates in the ventral tegmental area and projects to the nucleus accumbens, amygdala, hippocampus, and prefrontal cortex. This artificially increased dopamine concentration in reward sites reinforces drug-seeking behavior, a phenomenon known as the Dopamine Hypothesis of Addiction.

Addictive drugs target three molecular mechanisms: G protein-coupled receptors, ionotropic receptors and ion channels, and biogenic amine transporters. These targets alter neurotransmitter signaling and reuptake, producing reinforcing effects. Understanding these mechanisms is essential for developing effective addiction treatments and interventions.

Drug abuse risk involves three categories of factors: agent variables like drug potency and onset rapidity, host variables including genetic predisposition and psychiatric disorders, and environmental variables such as drug availability, social influences, and peer pressure. These factors interact to determine susceptibility to abuse and addiction.

As tolerance develops, users require higher doses to achieve the same effect. Self-medicating opioid users may exceed safe levels to overcome tolerance, significantly increasing overdose risk. Accidental overdoses have surpassed traffic accidents as a leading cause of mortality among young people in the US, highlighting the dangers of misunderstanding tolerance.

Withdrawal symptoms occur when drug use is abruptly stopped because the body must readjust from the pharmacologically induced imbalance. Physical dependence causes these symptoms as the body adapts back to normal function. Withdrawal severity depends on the drug type, duration of use, and individual factors, requiring medical management in many cases.

CNS stimulants like cocaine amphetamines and cannabinoids increase dopamine through distinct mechanisms, while CNS depressants affect different neurotransmitter systems. Each drug class interacts with specific molecular targets to produce reinforcement. Understanding these differences helps clinicians tailor addiction treatments to specific drug types and mechanisms.